TAMPA,
Fla. and CORAL SPRINGS,
Fla., Feb. 18, 2025 /PRNewswire/
-- HealthEdge Investment Partners, LLC ("HealthEdge"), a lower
middle market private equity fund focused on healthcare, announced
today that it has completed the sale of LifeSync ("LifeSync" or the
"Company"), a developer, manufacturer, and marketer of disposable
and reusable patient monitoring devices and connections sold to
hospitals and other high acuity settings. LifeSync was acquired by
Amphenol (NYSE: APH), one of the world's largest providers of
connectors, interconnect systems, antennas, sensors and specialty
cable.
"When we first invested in LifeSync, our objective was to grow
revenues and scale an entrepreneurial business with a great product
and unique IP," said Brian Anderson,
Managing Partner of HealthEdge. "We accomplished our goals and more
by appointing a new management team, completing four acquisitions
that added complementary products and vertically integrated
manufacturing, and reorganizing the company into its neuro, cardio,
and contract manufacturing divisions. In the process, LifeSync
touched millions of patients with its products, and grew revenues
from $5 million to approximately
$100 million. Given the strong
organic and acquisitive growth of the Company, this exit yielded
strong investment returns for HealthEdge Fund II."
"I am proud of the growth LifeSync has accomplished and the work
our global team does each day to provide critical medical products
to hospitals," added Bob Buehler,
General Manager of LifeSync. "HealthEdge has been an invaluable
partner to LifeSync as the Company has evolved during my tenure as
CEO. We are excited to join Amphenol and work on the Company's
future growth plans."
Hill Ward Henderson acted as
legal counsel and Lincoln International LLC served as financial
advisor to LifeSync on the sale.
ABOUT HEALTHEDGE
HealthEdge Investment Partners, LLC is an operating-oriented
private equity firm founded in 2005 that focuses exclusively on the
healthcare industry. HealthEdge seeks to achieve superior returns
by investing in businesses that benefit from the knowledge,
experience, and network of relationships of its partners.
HealthEdge's partners have more than 100 years of combined
experience in healthcare as operators and investors. For more
information on HealthEdge, please visit
www.healthedgepartners.com.
ABOUT LIFESYNC
LifeSync is the only vertically integrated company focused
solely on patient connections, providing cardiac cables, leadwires
and neuromonitoring connections in addition to contract
manufacturing solutions. Headquartered in Coral Springs, FL, LifeSync develops and
manufactures products at its state-of-the-art manufacturing
capabilities.
ABOUT AMPHENOL
Amphenol Corporation is one of the world's largest designers,
manufacturers and marketers of electrical, electronic and fiber
optic connectors and interconnect systems, antennas, sensors and
sensor-based products and coaxial and high-speed specialty
cable. Amphenol designs, manufactures and assembles its
products at facilities in approximately 40 countries around the
world and sells its products through its own global sales force,
independent representatives and a global network of electronics
distributors. Amphenol has a diversified presence as a leader
in high-growth areas of the interconnect market including:
Automotive, Commercial Aerospace, Communications Networks, Defense,
Industrial, Information Technology and Data Communications and
Mobile Devices. For more information, visit www.amphenol.com.
CONTACT:
HealthEdge Investment Partners, LLC
5550 W. Executive Drive, Suite 230
Tampa, Florida 33609
(813) 490-7100
www.healthedgepartners.com
View original
content:https://www.prnewswire.com/news-releases/healthedge-announces-successful-sale-of-lifesync-to-amphenol-302378866.html
SOURCE HealthEdge Investment Partners, LLC
